Basket cover image
17 handpicked stocks

Navigating The U.S. Manufacturing Contraction

The continued contraction of the U.S. manufacturing sector suggests a broader economic slowdown, prompting a potential shift in Federal Reserve policy. This environment could create opportunities in defensive stocks, such as those in the consumer staples and utilities sectors, which tend to be more resilient during economic downturns.

stock
stock
stock
stock
stock
stock
stock
stock
stock
stock

+7

Author avatar

Han Tan | Market Analyst

Updated today | Published at Aug 3

Top Picks from This Group

Here are a few of the assets in this group. Create an account to unlock the full list.

WTRG

Essential Utilities Inc.

WTRG

Current price

$38.33

UTL

UNITIL CORP

UTL

Current price

$52.13

CMS

CMS Energy Corp.

CMS

Current price

$74.67

About This Group of Stocks

1

Our Expert Thinking

With U.S. manufacturing contracting for five consecutive months, we're focusing on defensive sectors that historically perform well during economic slowdowns. These companies provide essential goods and services that people need regardless of economic conditions, making them potentially more resilient when growth slows.

2

What You Need to Know

This group emphasises consumer staples and utilities - sectors known for their stability and consistent dividend payments. These businesses tend to be less sensitive to economic cycles because they provide necessities like food, household products, and electricity that maintain steady demand even during tough times.

3

Why These Stocks

Each asset was handpicked by professional analysts based on their defensive characteristics and potential to provide stability during economic uncertainty. With the Federal Reserve potentially shifting towards more accommodative policy, these dividend-paying defensive stocks could become increasingly attractive to investors.

12 Month Growth Potential

Use the growth calculator to see how much investing in these assets could return over one year.

If you invested across these assets:

in 12 months it could be worth:

$1,000.00

+10.71%

Group Performance Snapshot

10.71%

Average 12 Month Profit

On average, analysts expect assets in this group to grow 10.71% over the next year.

7 of 17

Stocks Rated Buy by Analysts

7 of 17 assets in this group are rated Buy by professional analysts.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Why You'll Want to Watch These Stocks

🛡️

Recession-Proof Essentials

These companies provide the basics people can't live without - electricity, food, and household necessities. When economic storms hit, these businesses often weather them better than others.

💰

Steady Income Potential

Many of these defensive stocks are known for their reliable dividend payments. As interest rates potentially fall, these consistent income streams could become even more valuable to investors.

📉

Smart Timing Opportunity

With manufacturing weakness signalling potential economic headwinds, positioning in defensive sectors now could help protect your portfolio before broader market volatility increases.

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Unlock all the stocks in this group on Nemo

Sign up free to view all stocks in this group and never miss out on another investment opportunity with Nemo.

Sign up to Nemo FREE
At least 12 characters
Contains letters and numbers

By signing up you are agreeing to NemoMoney's T&C's

Sign up in 60 seconds

🆓

Zero commission trading

🛡️

SIPC-protected up to $500,000

🔒

Backed by Exinity Group

🚀

6% AER interest on uninvested cash, paid out daily

AI investment insights

Discover More Opportunities

Beyond Vaccines: The mRNA Revolution

Beyond Vaccines: The mRNA Revolution

BioNTech's strong vaccine sales are fueling its expansion into new medical fields, particularly cancer treatment. This strategic shift highlights a broader investment opportunity in companies pioneering the next wave of mRNA-based therapies.

View stocks
Navigating U.S. Drug Price Reforms

Navigating U.S. Drug Price Reforms

The White House is demanding major pharmaceutical companies slash U.S. drug prices, creating significant market volatility and threatening industry profits. This creates a potential opening for companies that offer cost-saving alternatives, such as generic drug makers and healthcare service providers.

View stocks
Aerospace Rivals In Focus Amid Labor Unrest

Aerospace Rivals In Focus Amid Labor Unrest

A significant strike by Boeing's defense workers in St. Louis is set to disrupt the production of crucial military aircraft. This development could create a strategic advantage for competing aerospace and defense firms poised to capture market share.

View stocks
View All Stock Groups

Frequently Asked Questions

Everything you need to know about the product and billing.